11:02 am Medtronic launches ‘TOTAL Across’ crossing catheter in Europe
moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click here to view […]
MDT
Medtronic Launches ‘TOTAL Across’ Crossing Catheter in Europe
[Thomson Reuters ONE] – New Peripheral Angioplasty Balloon Targets Challenging Lesions in Lower-Extremity, Including Below-the-Knee, Arteries Associated with Critical Limb Ischemia MINNEAPOLIS — Feb. 13, 2014 — Aligned with … moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click here to view […]
American College of Cardiology Journal Publishes Outcomes of Diabetes Patients Treated with Medtronic’s Resolute Stent
[at noodls] – Implanted Medical Device for Coronary Artery Disease Performed As Well In Study Subjects With Diabetes Who Were Not Taking Insulin As In Those Without Diabetes MINNEAPOLIS — April 15, 2013 — The current … moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click […]
Medtronic Initiates U.S. Trial to Evaluate the Use of Subcutaneous Peripheral Nerve Stimulation for Chronic Back Pain
[at noodls] – MINNEAPOLIS – April 11, 2013 – Medtronic, Inc. (NYSE: MDT) today announced the first patient enrollments in the SubQStim II pivotal clinical trial to pursue U.S. Food and Drug Administration (FDA) approval … moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click here […]
Medtronic Announces Public Offering of Senior Notes
[at noodls] – MINNEAPOLIS — March 19, 2013 — Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $1.0 billion of its 1.375% Senior Notes due 2018, $1.25 billion of its 2.750% Senior Notes due 2023 … moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click […]
With Medtronic Resolute Stent, Interrupting Dual Antiplatelet Therapy After One Month Showed No Increased Safety Risk in Robust Analysis
[at noodls] – ACC.13 Presentation Features Unprecedented Data on Nearly 5,000 Patients, Including All Comers, from Global RESOLUTE Clinical Program SAN FRANCISCO — March 11, 2013 — Cardiologists at ACC.13 … moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click here to view […]
Medtronic CFO Gary Ellis to Speak at Barclays Global Healthcare Conference
[at noodls] – MINNEAPOLIS – Mar 8, 2013 – Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Barclays Global Healthcare Conference on Wednesday, March … moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click here to view […]
Medtronic Submits IDE to FDA for U.S. Randomized Clinical Trial for Uncontrolled Hypertension Patients with Systolic Blood Pressure Between 140-160 mm Hg
[at noodls] – IDE Submission for Symplicity HTN-4 Expands the Indicated Patient Population and Builds upon Medtronic’s Rigorous Global Clinical Trial Program for Hypertension Treatment MINNEAPOLIS – March 7, 2013 – … moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click here to view […]
US broker round-up
moreView todays social media effects on MDTView the latest stocks trending across Twitter. Click to view dashboardSee who Medtronic is hiring next, click here to view […]
